含有混合类型的染色体:在药物化学中的合成和应用
Prashant S Auti1, Sakshi Jagetiya1, Atish T Paul1
1Laboratory of Natural Product Chemistry, Department of Pharmacy, Birla Institute of Technology and Science, Pilani (BITS Pilani), Pilani Campus, Pilani, 333031, Rajasthan, India.
Chemistry & biodiversity
|June 18, 2023
概括
基于染色体的分子混合物为药物发现提供了一个有前途的战略. 这篇评论详细介绍了它们的设计和合成,用于治疗肥胖,糖尿病,癌症,阿尔茨海默病和感染.
科学领域:
- 药用化学 医学化学
- 药物发现 药物发现 药物发现
- 有机合成 有机合成
背景情况:
- 像染色体这样的特权支架对于开发新型生物活性化合物至关重要.
- 分子杂交结合了药以增强药理活性.
- 染色体衍生物在各种治疗领域都显示出潜力.
研究的目的:
- 审查设计和合成基于染色体的分子混合物的策略.
- 探索这些混合体对抗主要疾病的结构-活性关系.
- 突出染色体混合体在药物发现中的治疗潜力.
主要方法:
- 关于染色体混合动力模拟设计和合成的文献综述.
- 对各种疾病点的结构-活性关系 (SAR) 的分析.
- 讨论混合类型的合成方法和方案.
主要成果:
- 具有多种碎片的染色体杂交物 (例如,多内,金胺,醇) 具有显著的生物活性.
- SAR研究揭示了针对肥胖,糖尿病,癌症,阿尔茨海默病和感染的关键结构特征.
- 提出了有效的合成路径来产生这些复杂的混合分子.
结论:
- 染色体支架的分子杂交是一种强大的药物发现方法.
- 染色体杂交体显示出各种具有挑战性的疾病的广泛治疗潜力.
- 本综述提供了对未来药物开发的合理设计和合成策略的见解.
更多相关视频
相关概念视频
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.1K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.1K
Preparation of Alkynes: Dehydrohalogenation
16.0K
Introduction
Alkynes can be prepared by dehydrohalogenation of vicinal or geminal dihalides in the presence of a strong base like sodium amide in liquid ammonia. The reaction proceeds with the loss of two equivalents of hydrogen halide (HX) via two successive E2 elimination reactions.
Alkynes can be prepared by dehydrohalogenation of vicinal or geminal dihalides in the presence of a strong base like sodium amide in liquid ammonia. The reaction proceeds with the loss of two equivalents of hydrogen halide (HX) via two successive E2 elimination reactions.
16.0K
Aryldiazonium Salts to Azo Dyes: Diazo Coupling
3.0K
The reaction of weakly electrophilic aryldiazonium (also called arenediazonium) salts with highly activated aromatic compounds leads to the formation of products with an —N=N— link, called an azo linkage. This reaction, presented in Figure 1, is known as diazo coupling and occurs without the loss of the nitrogen atoms of the aryldiazonium salt. Highly activated aromatic compounds such as phenols or arylamines favor the diazo coupling reaction. The coupling generally occurs at the...
3.0K
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
2.3K
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
2.3K
Aldehydes and Ketones with HCN: Cyanohydrin Formation Overview
2.9K
Cyanohydrins are compounds that contain –CN and –OH groups on the same carbon atom. They are formed by the nucleophilic addition of the cyanide ions to the carbonyl group. Cyanide ions are highly basic and nucleophilic and can be generated from HCN under aqueous conditions. However, since HCN is a weak acid, the number of cyanide ions generated is very small. Hence, a small amount of base or KCN/NaCN is added to HCN to increase the concentration of the cyanide ions in the reaction...
2.9K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
608
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
608


